Novartis, 2 Generics Drop Lotrel Patent Lawsuits
By Pete Brush ( September 25, 2009, 3:56 PM EDT) -- Novartis AG and two generic-drug makers have agreed to dismiss without prejudice a total of four patent lawsuits in which the U.S. arm of the Switzerland-based pharmaceutical giant had said applications to make generic versions of the hypertension drug Lotrel infringed its patent....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.